| Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the Global Burden of Disease Study 2021 KL Ong, LK Stafford, SA McLaughlin, EJ Boyko, SE Vollset, AE Smith, ... The Lancet 402 (10397), 203-234, 2023 | 567 | 2023 |
| Global Burden of Cardiovascular Diseases and Risks, 1990-2022 MA George A Mensah, Valentin Fuster, Christopher JL Murray, Gregory A Roth ... Journal of the American College of Cardiology 82 (25), 2350-2473, 2023 | 80 | 2023 |
| Coronary artery tortuosity: a narrative review F Kahe, S Sharfaei, A Pitliya, M Jafarizade, S Seifirad, S Habibi, G Chi Coronary artery disease 31 (2), 187-192, 2020 | 34 | 2020 |
| Eosinophilic inflammation in spontaneous coronary artery dissection: a potential therapeutic target? A Pitliya, S Datta, A Kalayci, F Kahe, S Sharfaei, M Jafarizade, S Goudarzi, ... Medical Hypotheses 121, 91-94, 2018 | 29 | 2018 |
| Global age-sex-specific mortality, life expectancy, and population estimates in 204 countries and territories and 811 subnational locations, 1950–2021, and the impact of the … AE Schumacher, HH Kyu, A Aali, C Abbafati, J Abbas, ... The Lancet 403 (10440), 1989-2056, 2024 | 28 | 2024 |
| Extended-duration betrixaban versus shorter-duration enoxaparin for venous thromboembolism prophylaxis in critically ill medical patients: an APEX trial substudy G Chi, CM Gibson, A Kalayci, AT Cohen, AF Hernandez, RD Hull, F Kahe, ... Intensive Care Medicine 45, 477-487, 2019 | 24 | 2019 |
| Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the … M Naghavi, KL Ong, A Aali, HS Ababneh, YH Abate, C Abbafati, ... The Lancet 403 (10440), 2100-2132, 2024 | 17 | 2024 |
| Global, regional, and national burden of disorders affecting the nervous system, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021 JD Steinmetz, KM Seeher, N Schiess, E Nichols, B Cao, C Servili, ... The Lancet Neurology 23 (4), 344-381, 2024 | 17 | 2024 |
| Global burden of peripheral artery disease and its risk factors, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019 MS Kim, J Hwang, DK Yon, SW Lee, SY Jung, S Park, CO Johnson, ... The Lancet Global Health 11 (10), e1553-e1565, 2023 | 14 | 2023 |
| Spontaneous coronary artery dissection and associated myocardial bridging: current evidence from cohort study and case reports FZ Tajrishi, A Ahmad, A Jamil, S Sharfaei, S Goudarzi, F Homayounieh, ... Medical Hypotheses 128, 50-53, 2019 | 14 | 2019 |
| COVID-19-associated coagulopathy: a concise review on pathogenesis and clinical implications SM Montazerin, H Najafi, F Shojaei, G Chi, S Goudarzi, S Sharfaei, ... Infez Med 29, 1-9, 2021 | 13 | 2021 |
| Global, regional, and national incidence of six major immune-mediated inflammatory diseases: findings from the global burden of disease study 2019 D Wu, Y Jin, Y Xing, MD Abate, M Abbasian, M Abbasi-Kangevari, ... EClinicalMedicine 64, 2023 | 11 | 2023 |
| The role of interleukin-27 in atherosclerosis: A contemporary review M Jafarizade, F Kahe, S Sharfaei, K Momenzadeh, A Pitliya, ... Cardiology 146 (4), 517-530, 2021 | 9 | 2021 |
| Extended or shorter prophylaxis for venous thromboembolism in acutely ill hospitalized patients: updated meta-analysis of randomized trials G Chi, S Sharfaei, M Jafarizade, F Kahe, Y Liu Vascular Medicine 24 (2), 156-158, 2019 | 6 | 2019 |
| Betrixaban for first-line venous thromboembolism prevention in acute medically ill patients with risk factors for venous thromboembolism T Nafee, CM Gibson, MK Yee, F Alkhalfan, G Chi, R Travis, M Mir, ... Expert review of cardiovascular therapy 16 (11), 845-855, 2018 | 5 | 2018 |
| Burden of disease scenarios for 204 countries and territories, 2022–2050: a forecasting analysis for the Global Burden of Disease Study 2021 SE Vollset, HS Ababneh, YH Abate, C Abbafati, R Abbasgholizadeh, ... The Lancet 403 (10440), 2204-2256, 2024 | 4 | 2024 |
| Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease … M Brauer, GA Roth, AY Aravkin, P Zheng, KH Abate, YH Abate, C Abbafati, ... The Lancet 403 (10440), 2162-2203, 2024 | 4 | 2024 |
| Global fertility in 204 countries and territories, 1950–2021, with forecasts to 2100: a comprehensive demographic analysis for the Global Burden of Disease Study 2021 NV Bhattacharjee, AE Schumacher, A Aali, YH Abate, R Abbasgholizadeh, ... The Lancet 403 (10440), 2057-2099, 2024 | 4 | 2024 |
| The AngelMed Guardian® System in the Detection of Coronary Artery Occlusion: Current Perspectives SHA Kazmi, S Datta, G Chi, T Nafee, M Yee, A Kalia, S Sharfaei, ... Medical Devices: Evidence and Research, 1-12, 2020 | 3 | 2020 |
| Commentary: Association of Anemia with Venous Thromboembolism in Acutely Ill Hospitalized Patients: An APEX Trial Substudy A Pitliya, A Ahmad, H Shaukat, E Ghaffarpasand, S Sharfaei, F Kahe, ... Journal of Lung Health and Diseases 2 (3), 2018 | 2 | 2018 |
Gerald ChiBeth Israel Deaconess Medical Center, Harvard Medical SchoolVerified email at perfuse.org
